Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis
about
Comparison of the effect of increased hepatitis B vaccine dosage on immunogenicity in healthy children and adultsPossible Impact of 190G > A CCR2 and Δ32 CCR5 Mutations on Decrease of the HBV Vaccine Immunogenicity-A Preliminary Report.The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience.Low Immunogenicity of Recombinant Hepatitis B Vaccine Derived from Hansenula polymorpha in Adults Aged Over 40 Years.Guidelines for the prevention of travel-associated illness in older adults.Impaired Immune Response to Primary but Not to Booster Vaccination Against Hepatitis B in Older Adults.
P2860
Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Characterization of an age-res ...... adults: An integrated analysis
@ast
Characterization of an age-res ...... adults: An integrated analysis
@en
type
label
Characterization of an age-res ...... adults: An integrated analysis
@ast
Characterization of an age-res ...... adults: An integrated analysis
@en
prefLabel
Characterization of an age-res ...... adults: An integrated analysis
@ast
Characterization of an age-res ...... adults: An integrated analysis
@en
P2093
P2860
P1476
Characterization of an age-res ...... adults: An integrated analysis
@en
P2093
Brigitte Cheuvart
Marc De Ridder
Olivier Van Der Meeren
Priya Crasta
P2860
P304
P356
10.1080/21645515.2015.1039758
P577
2015-07-01T00:00:00Z